100 related articles for article (PubMed ID: 9665752)
1. Down-regulation of Fas-associated phosphatase-1 (FAP-1) in interleukin-2-activated T cells.
Zhou YW; Komada Y; Inaba H; Azuma E; Sakurai M
Cell Immunol; 1998 Jun; 186(2):103-10. PubMed ID: 9665752
[TBL] [Abstract][Full Text] [Related]
2. Expression of FAP-1 by human colon adenocarcinoma: implication for resistance against Fas-mediated apoptosis in cancer.
Yao H; Song E; Chen J; Hamar P
Br J Cancer; 2004 Nov; 91(9):1718-25. PubMed ID: 15494722
[TBL] [Abstract][Full Text] [Related]
3. Spontaneous down-regulation of Fas-associated phosphatase-1 may contribute to excessive apoptosis in myelodysplastic marrows.
Mundle SD; Mativi BY; Bagai K; Feldman G; Cheema P; Gautam U; Reza S; Cartlidge JD; Venugopal P; Shetty V; Gregory SA; Robin E; Rifkin S; Shah R; Raza A
Int J Hematol; 1999 Aug; 70(2):83-90. PubMed ID: 10497846
[TBL] [Abstract][Full Text] [Related]
4. The Src-homology domain 2-bearing protein tyrosine phosphatase-1 inhibits antigen receptor-induced apoptosis of activated peripheral T cells.
Zhang J; Somani AK; Watt S; Mills GB; Siminovitch KA
J Immunol; 1999 Jun; 162(11):6359-67. PubMed ID: 10352248
[TBL] [Abstract][Full Text] [Related]
5. Fas-mediated apoptosis and expression of related genes in human malignant hematopoietic cells.
Kim KM; Lee K; Hong YS; Park HY
Exp Mol Med; 2000 Dec; 32(4):246-54. PubMed ID: 11190279
[TBL] [Abstract][Full Text] [Related]
6. Cholangiocarcinomas express Fas ligand and disable the Fas receptor.
Que FG; Phan VA; Phan VH; Celli A; Batts K; LaRusso NF; Gores GJ
Hepatology; 1999 Dec; 30(6):1398-404. PubMed ID: 10573518
[TBL] [Abstract][Full Text] [Related]
7. Expression of membrane-bound and soluble FasL in Fas- and FADD-dependent T lymphocyte apoptosis induced by mildly oxidized LDL.
Alcouffe J; Therville N; Ségui B; Nazzal D; Blaes N; Salvayre R; Thomsen M; Benoist H
FASEB J; 2004 Jan; 18(1):122-4. PubMed ID: 14630709
[TBL] [Abstract][Full Text] [Related]
8. In vivo expression of soluble Fas and FAP-1: possible mechanisms of Fas resistance in human hepatoblastomas.
Lee SH; Shin MS; Lee JY; Park WS; Kim SY; Jang JJ; Dong SM; Na EY; Kim CS; Kim SH; Yoo NJ
J Pathol; 1999 Jun; 188(2):207-12. PubMed ID: 10398166
[TBL] [Abstract][Full Text] [Related]
9. Cytokine associated sensitivity of colon carcinoma cells to FasR-mediated cytotoxicity of CTL.
Chen J; Zhang H; Su F; Min J; Zhang J; Song E
Asian J Surg; 2002 Jan; 25(1):89-97. PubMed ID: 17585452
[TBL] [Abstract][Full Text] [Related]
10. Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector molecule.
Holler N; Zaru R; Micheau O; Thome M; Attinger A; Valitutti S; Bodmer JL; Schneider P; Seed B; Tschopp J
Nat Immunol; 2000 Dec; 1(6):489-95. PubMed ID: 11101870
[TBL] [Abstract][Full Text] [Related]
11. FADD deficiency sensitises Jurkat T cells to TNF-alpha-dependent necrosis during activation-induced cell death.
Lawrence CP; Chow SC
FEBS Lett; 2005 Nov; 579(28):6465-72. PubMed ID: 16289096
[TBL] [Abstract][Full Text] [Related]
12. Human pancreatic adenocarcinomas express Fas and Fas ligand yet are resistant to Fas-mediated apoptosis.
Ungefroren H; Voss M; Jansen M; Roeder C; Henne-Bruns D; Kremer B; Kalthoff H
Cancer Res; 1998 Apr; 58(8):1741-9. PubMed ID: 9563493
[TBL] [Abstract][Full Text] [Related]
13. Primed T cells are more resistant to Fas-mediated activation-induced cell death than naive T cells.
Inaba M; Kurasawa K; Mamura M; Kumano K; Saito Y; Iwamoto I
J Immunol; 1999 Aug; 163(3):1315-20. PubMed ID: 10415029
[TBL] [Abstract][Full Text] [Related]
14. Cell cycle-dependent regulation of FLIP levels and susceptibility to Fas-mediated apoptosis.
Algeciras-Schimnich A; Griffith TS; Lynch DH; Paya CV
J Immunol; 1999 May; 162(9):5205-11. PubMed ID: 10227994
[TBL] [Abstract][Full Text] [Related]
15. Expression of genes that regulate Fas signalling and Fas-mediated apoptosis in colon carcinoma cells.
Tillman DM; Harwood FG; Gibson AA; Houghton JA
Cell Death Differ; 1998 May; 5(5):450-7. PubMed ID: 10200495
[TBL] [Abstract][Full Text] [Related]
16. mRNA expression of Fas receptor (CD95)-associated proteins (Fas-associated phosphatase-1/FAP-1, Fas-associating protein with death domain/FADD, and receptor-interacting protein/RIP) in human leukaemia/lymphoma cell lines.
Komada Y; Inaba H; Zhou YW; Zhang XL; Tanaka S; Azuma E; Sakurai M
Br J Haematol; 1997 Nov; 99(2):325-30. PubMed ID: 9375749
[TBL] [Abstract][Full Text] [Related]
17. Induction of T cell clonal anergy results in resistance, whereas CD28-mediated costimulation primes for susceptibility to Fas- and Bax-mediated programmed cell death.
Boussiotis VA; Lee BJ; Freeman GJ; Gribben JG; Nadler LM
J Immunol; 1997 Oct; 159(7):3156-67. PubMed ID: 9317113
[TBL] [Abstract][Full Text] [Related]
18. Expression of Fas and Fas-related molecules in human hepatocellular carcinoma.
Lee SH; Shin MS; Lee HS; Bae JH; Lee HK; Kim HS; Kim SY; Jang JJ; Joo M; Kang YK; Park WS; Park JY; Oh RR; Han SY; Lee JH; Kim SH; Lee JY; Yoo NJ
Hum Pathol; 2001 Mar; 32(3):250-6. PubMed ID: 11274632
[TBL] [Abstract][Full Text] [Related]
19. Fas-mediated apoptosis and activation-induced T-cell proliferation are defective in mice lacking FADD/Mort1.
Zhang J; Cado D; Chen A; Kabra NH; Winoto A
Nature; 1998 Mar; 392(6673):296-300. PubMed ID: 9521326
[TBL] [Abstract][Full Text] [Related]
20. Metabolic inhibitors sensitize for CD95 (APO-1/Fas)-induced apoptosis by down-regulating Fas-associated death domain-like interleukin 1-converting enzyme inhibitory protein expression.
Fulda S; Meyer E; Debatin KM
Cancer Res; 2000 Jul; 60(14):3947-56. PubMed ID: 10919673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
